Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Physiomer is a leading European consumer healthcare brand specializing in natural, seawater-based nasal care solutions. Originally developed by Laboratoire de la Mer in Saint-Malo, France, the brand utilizes a unique 100% natural seawater formula that is desalinated via electrodialysis to maintain essential minerals and trace elements. Its product portfolio includes a wide range of nasal sprays, washes, and decongestants designed for infants, children, and adults to treat respiratory conditions such as allergic rhinitis and chronic sinusitis. Physiomer is currently a core brand within the global portfolio of Perrigo Company plc, following its acquisition of Omega Pharma. The brand is recognized for its clinical efficacy in clearing nasal passages and supporting the immune defense of the nasal mucosa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Physiomer.